Sales ContractHorizon Pharma, Inc. • October 8th, 2010 • Pharmaceutical preparations • Delaware
BASF Corporation, with offices at 100 Campus Drive, Florham Park, New Jersey 07932 (“Seller”) hereby agrees to sell Product to: Horizon Pharma USA, Inc. (“Buyer”), with offices at 1033 Skokie Boulevard, Suite 355, Northbrook, Illinois, 60062, and Buyer hereby agrees to purchase Product from Seller for shipment to locations designated by Buyer in USA, Canada or the European Union according to the following terms and conditions:
HORIZON PHARMA, INC. INVESTORS’ RIGHTS AGREEMENT April 1, 2010Investors’ Rights Agreement • October 8th, 2010 • Horizon Pharma, Inc. • Pharmaceutical preparations • Delaware
This Investors’ Rights Agreement (this “Agreement”) is made as of April 1, 2010 by and among Horizon Pharma, Inc., a Delaware corporation (the “Company”), the holders of the Company’s Series A Preferred Stock listed on Exhibit A attached hereto (the “Series A Holders”), and the holders of the Company’s Series B Preferred Stock listed on Exhibit B attached hereto (the “Series B Holders” and together with the Series A Holders, referred to herein each individually as an “Investor” and collectively, as the “Investors”).
